Enter at least 4 characters

1 results showing for: 'eftrenonacog alfa [recombinant factor ix]'

[Xpharm]
  • Inj 250 iu vial
    • Brand Fully subsidised brand. Alprolix
    • Pharmacode2565846
    • Subsidy $612.50
    • Measure / Qty per 1
  • Inj 500 iu vial
    • Brand Fully subsidised brand. Alprolix
    • Pharmacode2565854
    • Subsidy $1225.00
    • Measure / Qty per 1
  • Inj 1,000 iu vial
    • Brand Fully subsidised brand. Alprolix
    • Pharmacode2565862
    • Subsidy $2450.00
    • Measure / Qty per 1
  • Inj 2,000 iu vial
    • Brand Fully subsidised brand. Alprolix
    • Pharmacode2565870
    • Subsidy $4900.00
    • Measure / Qty per 1
  • Inj 3,000 iu vial
    • Brand Fully subsidised brand. Alprolix
    • Pharmacode2565889
    • Subsidy $7350.00
    • Measure / Qty per 1
  • Inj 4,000 iu vial
    • Brand Fully subsidised brand. Alprolix
    • Pharmacode2636069
    • Subsidy $9800.00
    • Measure / Qty per 1

For patients with haemophilia B receiving prophylaxis treatment. Access to funded treatment is managed by the Haemophilia Treaters Group in conjunction with the National Haemophilia Management group.

  • Rectangle page icon symoblising a PDF. PDF
  • A tick icon. Fully subsidised
  • An oval with the number 29 in it. Unapproved medicine under Section 29
  • An asterisk symbol. 3 or 6 months should be dispensed at once
  • Two duplicate pages icon. Click to copy
  • A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
  • OP Original pack
  • Sole Subsidised Supply